Stock Quote
Wyeth (WYE.BA) (Buenos Aires Stock Exchange)
$49.05
28 Nov 2008
+0.00%
$49.05
--
1,444
$49.05
$49.05
$48.16
$48.16
0.38
0
WYE.BA
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Poussot, Bernard | Chairman of the Board, President, Chief Executive Officer | 21,357,396 |
| Norden, Gregory | Chief Financial Officer, Senior Vice President | 7,731,675 |
| DeLuca, Richard | President - Fort Dodge Animal Health | -- |
Profile
Wyeth is engaged in the discovery, development, manufacture, distribution and sale of a line of products in three primary businesses: Wyeth Pharmaceuticals (Pharmaceuticals), Wyeth Consumer Healthcare (Consumer Healthcare), and Fort Dodge Animal Health (Animal Health). Pharmaceuticals include... Full Description
Company Address
Wyeth
Five Giralda Farms
Madison NJ 07940
P: +1973.6605000
F: +1973.6605771
Five Giralda Farms
Madison NJ 07940
P: +1973.6605000
F: +1973.6605771
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Merck & Co., Inc. | $36.42 | -0.04 |
| Sanofi-Aventis SA | €51.64 | -0.13 |
| Novartis AG | CHF55.70 | +0.55 |
| WYE.BA | Industry | |
|---|---|---|
| P/E(TTM) | 14.89 | 6.90 |
| P/S(TTM) | 3.02 | 1.54 |
| ROI(TTM) | 12.03 | 6.18 |
| ROE(TTM) | 22.54 | 9.32 |
| Consensus Recommendation | Buy |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | 3.58 |
| Total Revenue | $5,695.16M |
| Net Income | $1,272.02M |
| EPS | $0.94 |
